Brief: Exopharm Posts FY Revenues From Ordinary Activities A$102.7 Mln

Entropy Neurodynamics

31/08/2022 24:10

Aug 31 (Reuters) - Exopharm Ltd  EX1.AX :
    * FY REVENUES FROM ORDINARY ACTIVITIES A$102.7 MILLION
    * FY LOSS AFTER INCOME TAX EXPENSE ATTRIBUTABLE A$10.1
MILLION
VERSUS LOSS A$8.5 MILLION

Source text for Eikon:  ID:nASX7cfCTz 
Further company coverage:  EX1.AX 

 ((Reuters.Briefs@thomsonreuters.com;))